Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 801–900 of 1,062
Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease
Zhou, Q., & Liao, J. K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789057986 · Cited by 124
“Indeed, statins prevent the synthesis of other important isoprenoid intermediates of the cholesterol biosynthetic pathway, such as farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) that are downstream from L-mevalonic acid [22].”
BackgroundHassanabad, A. F. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.09.08 · Cited by 114
Schumacher, M. M., & DeBose‐Boyd, R. A. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-081820-101010 · Cited by 123
Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors
Jamal, S. M., Eisenberg, M. J., & Christopoulos, S. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.037 · Cited by 123
Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion
Naidu, B. V., Woolley, S. M., Farivar, A. S., Thomas, R., Fraga, C. H., & Mulligan, M. S. (2003) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00699-8 · Cited by 111
“Discussion The pleiotropic effects of statins seem to result from the inhibition of cholesterol’s precursor mevalonic acid, which is critical to the isoprenylation of diverse group of proteins.(17) Two functionally distinct pathways of prenylation covalently attach a lipid (geranylgeranyl or farnesyl) to different gro…”
BackgroundOhashi, K., Osuga, J.-I., Tozawa, R., Kitamine, T., Yagyu, H., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., Yahagi, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307228200 · Cited by 110
Shibata, S., Nagase, M., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050571 · Cited by 114
“Statins also suppress isoprenoid biosynthesis via inhibition of the mevalonate pathway (6).”
BackgroundSmith, T. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.4.703 · Cited by 111
Prospects for the bioengineering of isoprenoid biosynthesis
McCaskill, D. G., & Croteau, R. (1997) · Advances in biochemical engineering, biotechnology · doi:10.1007/bfb0102064 · Cited by 112
Meigs, T. E., & Simoni, R. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0200 · Cited by 128
Spady, D. K., & Cuthbert, J. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42805-0 · Cited by 111
UPRmt-mediated cytoprotection and organismal aging
Schulz, A. M., & Haynes, C. M. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.03.008 · Cited by 110
“many small GTPases), statin-mediated inhibition can causemultiple undesirable off-target effects [75].”
BackgroundMenzies, S. A., Volkmar, N., van den Boomen, D. J., Timms, R. T., Dickson, A. S., Nathan, J. A., & Lehner, P. J. (2018) · eLife · doi:10.7554/elife.40009 · Cited by 117
Squalene monooxygenase: a journey to the heart of cholesterol synthesis
Chua, N. K., Coates, H. W., & Brown, A. J. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101033 · Cited by 112
Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism
Kim, H., Oh, B., & Park‐Min, K. (2021) · Cells · doi:10.3390/cells10010089 · Cited by 124
Relja, B. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000520 · Cited by 110
“…for alternative strategies focusing on HCC. Simvastatin, one of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, is currently widely used safe and well tolerated therapeutic agent for treating hypercholesterolemia, atherosclerosis, coronary heart disease and stroke (12).”
Singh, B. M., & Mehta, J. L. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1296 · Cited by 118
Plat, J., & Mensink, R. P. (2001) · The FASEB Journal · doi:10.1096/fj.01-0653fje · Cited by 110
“The transcription of the ratelimiting enzyme for endogenous cholesterol synthesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, is controlled in a similar way (3), although its activity depends on posttranscriptional modifications (4).”
BackgroundKoning, A. J., Roberts, C. J., & Wright, R. L. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.5.769 · Cited by 111
Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome after Six Months of Treatment
Banaszewska, B., Pawelczyk, L., Spaczynski, R. Z., & Duleba, A. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0501 · Cited by 108
“immediate and direct competitive inhibition of the ratelimiting step of cholesterol synthesis via 3-hydroxy3methylglutaryl-coenzyme A reductase (33).”
BackgroundSome caveats for bioengineering terpenoid metabolism in plants
McCaskill, D. G., & Croteau, R. (1998) · Trends in biotechnology · doi:10.1016/s0167-7799(98)01231-1 · Cited by 112
Immunomodulatory Effects of Statins: Mechanisms and Potential Impact on Arteriosclerosis
Palinski, W., & Tsimikas, S. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018400.39687.8c · Cited by 120
Pandyra, A. A., Mullen, P., Kalkat, M., Yu, R., Pong, J. T., Li, Z., Trudel, S., Lang, K. S., Minden, M. D., Schimmer, A. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0130 · Cited by 120
“the mevalonate (MVA) pathway, HMGCR (3), are used in the treatment of patients with hypercholesterolemia (Fig.”
BackgroundThe Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins
Murphy, C., Deplazes, E., Cranfield, C. G., & Garcia, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228745 · Cited by 127
“The enzyme is not only pivotal in the formation of sterols, but also other biological molecules including derivatives of isoprenoids, like ubiquinone (CoQ10) and prenylated proteins [64].”
BackgroundHoriuchi, N., & Maeda, T. (2006) · Oral Diseases · doi:10.1111/j.1601-0825.2005.01172.x · Cited by 123
Cellular responses to environmental salinity in the halophilic black yeast Hortaea werneckii
Petrovič, U., Gunde‐Cimerman, N., & Plemenitaš, A. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03021.x · Cited by 127
“HMGR is a key regulatory enzyme of the mevalonate pathway whose main products in eukaryotes are sterols (Brown and Goldstein, 1990).”
BackgroundLocalization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments
Garver, W. S., Heidenreich, R. A., Erickson, R. P., Thomas, M. A., & Wilson, J. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32376-2 · Cited by 109
Houten, S. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.25.3115 · Cited by 109
Schafer, B. L., Bishop, R. W., Kratunis, V. J., Kalinowski, S. S., Mosley, S. T., Gibson, K. M., & Tanaka, R. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42199-0 · Cited by 109
Indolfi, C., Lorenzo, E. D., Perrino, C., Stingone, A. M., Curcio, A., Torella, D., Cittadini, A., Cardone, L., Coppola, C., Cavuto, L., et al. (2002) · Circulation · doi:10.1161/01.cir.0000034047.70205.97 · Cited by 110
Biosynthesis of Mevalonic Acid from Acetyl-CoA
Bochar, D. A., Freisen, J., Stauffacher, C. V., & Rodwell, V. W. (1999) · Elsevier eBooks · doi:10.1016/b978-0-08-091283-7.00035-7 · Cited by 124
Signals and genes in the control of cell-cycle progression
Müller, R., Mumberg, D., & Lucibello, F. C. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90003-u · Cited by 123
Shibuya, Y., Chang, C. C. Y., Huang, L.-H., Bryleva, E. Y., & Chang, T.-Y. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2567-14.2014 · Cited by 108
“In cells treated with statin, we also provided mevalonate in growth medium, such that the statin effect is mainly on cholesterol, but not on mevalonatederived nonsterol metabolites (Goldstein and Brown, 1990).”
BackgroundDefects of cholesterol biosynthesis
Waterham, H. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.027 · Cited by 108
“Although since then many conflicting reports on this topic appeared, these studies led to the postulation that peroxisomes would be directly involved in isoprenoid/cholesterol biosynthesis (reviewed in [1,5]).”
BackgroundInfluentialComparative genomics reveals candidate carotenoid pathway regulators of ripening watermelon fruit
Grassi, S., Piro, G., Lee, J. M., Zheng, Y., Fei, Z., Dalessandro, G., Giovannoni, J. J., & Lenucci, M. S. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-781 · Cited by 123
“It is a highly regulated enzyme, being subjected to transcriptional, translational, and post-translational control [47].”
BackgroundChen, L., Ma, M.-Y., Sun, M., Jiang, L.-Y., Zhao, X.-T., Fang, X.-X., Man Lam, S., Shui, G.-H., Luo, J., Shi, X.-J., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000201 · Cited by 109
“Mevalonate is a key intermediate synthesized from HMG-CoA by HMG-CoA reductase (HMGCR), an ER-localized ratelimiting enzyme of the mevalonate pathway (8).”
BackgroundWang, W., Yang, L., & Huang, H. W. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.097923 · Cited by 118
“Only small pools of cholesterol are in intracellular membranes, including endoplasmic reticulum, nuclear membranes, Golgi apparatus, mitochondria, lysosomes, and peroxisomes (42,43).”
Frøyland, L., Vaagenes, H., Asiedu, D. K., Garras, A., Lie, Ø., & Berge, R. K. (1996) · Lipids · doi:10.1007/bf02522617 · Cited by 107
Jiang, X., Masucci-Magoulas, L., Mar, J., Lin, M., Walsh, A., Breslow, J. L., & Tall, A. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74263-x · Cited by 108
Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis
Metherall, J. E., Li, H., & Waugh, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2634 · Cited by 109
Molecular Cloning and Functional Analysis of the Promoter of the Human Squalene Synthase Gene
Guan, G., Jiang, G., Koch, R. L., & Shechter, I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21958 · Cited by 108
Inoue, S., Bar‐Nun, S., Roitelman, J., & Simoni, R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98840-x · Cited by 108
Jiang, P., Mukthavavam, R., Chao, Y., Bharati, I. S., Fogal, V., Pastorino, S., Cong, X., Nomura, N., Gallagher, M., Abbasi, T., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-13 · Cited by 110
“[44].”
Tanaka, T., Tatsuno, I., Uchida, D., Moroo, I., Morio, H., Nakamura, S., Noguchi, Y., Yasuda, T., Kitagawa, M., Saito, Y., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02852.2000 · Cited by 107
“The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, which converts HMG-CoA to mevalonate, is a rate-limiting enzyme of the mevalonate cascade (Goldstein and Brown, 1990).”
BackgroundRegulation of Hmg-Coa Reductase Degradation Requires the P-Type Atpase Cod1p/Spf1p
Cronin, S. R., Khoury, A., Ferry, D. K., & Hampton, R. Y. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.915 · Cited by 110
“HMGR is subject to numerous modes of regulation, including feedback control of HMGR stability (Edwards et al., 1983; Chun et al., 1990; Goldstein and Brown, 1990).”
BackgroundTakeuchi, S., Kawashima, S., Rikitake, Y., Ueyama, T., Inoue, N., Hirata, K., & Yokoyama, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2238 · Cited by 107
Guan, G., Dai, P.-H., Osborne, T. F., Kim, J. B., & Shechter, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10295 · Cited by 107
Cholesterol biosynthesis and ER stress in peroxisome deficiency
Faust, P. L., & Kovacs, W. J. (2014) · Biochimie · doi:10.1016/j.biochi.2013.10.019 · Cited by 107
Metabolic enzymes that bind RNA: yet another level of cellular regulatory network?
Cieśla, J. (2006) · Acta Biochimica Polonica · doi:10.18388/abp.2006_3360 · Cited by 106
“Increased cellular cholesterol inhibits sterol-responsive genes, including key enzymes in cholesterol synthesis (Brown & Goldstein, 1990).”
Jiang, B., Brown, J. L., Sheraton, J., Fortin, N., & Bussey, H. (1994) · Yeast · doi:10.1002/yea.320100307 · Cited by 107
“These actions coordinately limit the synthesis and uptake of cholesterol, thereby preventing cholesterol accumulation within cells (Goldstein and Brown, 1990).”
BackgroundVeillard, N. R., & Mach, F. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012505 · Cited by 127
Prenylated Prelamin A Interacts with Narf, a Novel Nuclear Protein
Barton, R. M., & Worman, H. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30008 · Cited by 107
Cloning of the human cholesterol 7α-hydroxylase gene (CYP7) and localization to chromosome 8q11–q12
Cohen, J. C., Cali, J. J., Jelinek, D. F., Mehrabian, M., Sparkes, R. S., Lusis, A. J., Russell, D. W., & Hobbs, H. H. (1992) · Genomics · doi:10.1016/s0888-7543(05)80298-8 · Cited by 106
Fungal lipopeptide mating pheromones: A model system for the study of protein prenylation
Caldwell, G. A., Naider, F., & Becker, J. M. (1995) · Microbiological Reviews · doi:10.1128/mr.59.3.406-422.1995 · Cited by 172
Samid, D., Ram, Z., Hudgins, W. R., Shack, S., Liu, L., Walbridge, S., Oldfield, E. H., & Myers, C. E. (1994) · PubMed · Cited by 106
NF-Y Has a Novel Role in Sterol-dependent Transcription of Two Cholesterogenic Genes
Jackson, S. M., Ericsson, J., Osborne, T. F., & Edwards, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21445 · Cited by 106
Lipid metabolism reprogramming in renal cell carcinoma
Heravi, G., Yazdanpanah, O., Podgorski, I., Matherly, L. H., & Liu, W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09996-w · Cited by 125
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., Drogari, E., & Ramaswami, U. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub5 · Cited by 131
Guo, C., Wan, R., He, Y., Lin, S., Cao, J., Qiu, Y., Zhang, T., Zhao, Q., Niu, Y., Jin, Y., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00358-1 · Cited by 113
Ahn, K. S., Sethi, G., & Aggarwal, B. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2507 · Cited by 104
“Alternatively, it is possible that simvastatin suppresses IKK and subsequent NF- B activation through the inhibition of farnesylation of Ras or other related proteins (4, 66).”
BackgroundYu, S. G., Hildebrandt, L. A., & Elson, C. E. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.11.2763 · Cited by 105
ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance
de Jonge-Peeters, S. D. P. W. M., Kuipers, F., de Vries, E. G. E., & Vellenga, E. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.02.003 · Cited by 120
“[149] Goldstein JL, Brown MS.”
SIRT1 and SIRT3 Deacetylate Homologous Substrates: AceCS1,2 and HMGCS1,2
Hirschey, M. D., Shimazu, T., Capra, J. A., Pollard, K. S., & Verdin, E. (2011) · Aging · doi:10.18632/aging.100339 · Cited by 104
Paul, S., & Lal, G. (2016) · International Journal of Cancer · doi:10.1002/ijc.30109 · Cited by 105
“Tumor cells have an active mevalonate pathway(53) and produce isoprenoids such as IPP, which help in cell growth and survival.(54) Many of the mevalonate pathway intermediates, including IPP, were shown to activate human Vg9Vd2 T cells and promote anti-tumor response.”
BackgroundVitols, S., Norgren, S., Juliusson, G., Tatidis, L., & Luthman, H. (1994) · Blood · doi:10.1182/blood.v84.8.2689.2689 · Cited by 104
Rodríguez-Concepción, M., Campos, N., Lois, L. M., Maldonado, C., Hoeffler, J., Grosdemange‐Billiard, C., Rohmer, M., & Boronat, A. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01552-0 · Cited by 112
Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers
Henninger, C., & Fritz, G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.418 · Cited by 110
Cholesterol-Recognition Motifs in Membrane Proteins
Fantini, J., Epand, R. M., & Barrantes, F. J. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-14265-0_1 · Cited by 103
Matsumoto, M., Einhaus, D., Gold, E. S., & Aderem, A. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7377 · Cited by 115
“T he 3-hydroxyl-3-methylglutaryl-coenzyme A (HMGCoA)(3) reductase is the rate-limiting enzyme in cholesterol biosynthesis (1).”
BackgroundSchulz, J. G., Bösel, J., Stoeckel, M., Megow, D., Dirnagl, U., & Endres, M. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02305.x · Cited by 104
Structure and regulation of mammalian squalene synthase
Tansey, T. R., & Shechter, I. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00137-2 · Cited by 117
Dimitroulakos, J., & Yeger, H. (1996) · Nature Medicine · doi:10.1038/nm0396-326 · Cited by 104
Post-translational chemical modification(S) of proteins
Han, K., & Martinage, A. (1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90225-p · Cited by 107
Flores‐Morales, A., Ståhlberg, N., Tollet‐Egnell, P., Lundeberg, J., Malek, R. L., Quackenbush, J. F., Lee, N. H., & Norstedt, G. (2001) · Endocrinology · doi:10.1210/en.142.7.3163 · Cited by 109
Proteolysis and Sterol Regulation
Hampton, R. Y. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.032002.131219 · Cited by 104
Francone, O. L., Royer, L. J., & Haghpassand, M. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39156-2 · Cited by 106
Nutritional factors and colon cancer
Reddy, B. S., & Shamsudden, A. K. M. (1995) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399509527698 · Cited by 104
Sterol-resistant transcription in CHO cells caused by gene rearrangement that truncates SREBP-2.
Yang, J., Sato, R., Goldstein, J. L., & Brown, M. S. (1994) · Genes & Development · doi:10.1101/gad.8.16.1910 · Cited by 104
Self-citationEffect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
Lee, J., Lee, I., Han, B., Park, J. O., Jang, J., Park, C., & Kang, W. K. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr070 · Cited by 103
Pharmacogenetics and human genetic polymorphisms
Daly, A. K. (2010) · Biochemical Journal · doi:10.1042/bj20100522 · Cited by 103
A bibliometric study of highly cited reviews in the S cience C itation I ndex expanded™
Ho, Y., & Kahn, M. (2013) · Journal of the Association for Information Science and Technology · doi:10.1002/asi.22974 · Cited by 117
““Regulation of the Mevalonate Pathway” (Goldstein & Brown, 1990) by Goldstein as the first and corresponding authors was the most-cited Goldstein review with TC2011 = 3,120.”
BackgroundActivation of Mevalonate Pathway Via LKB1 is Essential for Stability of Treg Cells
Timilshina, M., You, Z., Lacher, S. M., Acharya, S., Jiang, L., Kang, Y., Kim, J., Chang, H. W., Kim, K., Park, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.020 · Cited by 113
CAAX-box protein, prenylation process and carcinogenesis.
Gao, J., Liao, J., & Yang, G. (2009) · PubMed Central · Cited by 143
Amaranth and Its Oil Inhibit Cholesterol Biosynthesis in 6-Week-Old Female Chickens
Qureshi, A. A., Lehmann, J., & Peterson, D. M. (1996) · Journal of Nutrition · doi:10.1093/jn/126.8.1972 · Cited by 103
Zhou, J., Wang, C., Yoon, S., Jang, H., Choi, E., & Kim, S.-W. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.11.009 · Cited by 104
Relevance of trichothecenes in fungal physiology: Disruption of tri5 in Trichoderma arundinaceum
Malmierca, M. G., Cardoza, R. E., Alexander, N. J., McCormick, S. P., Collado, I. G., Hermosa, R., Monte, E., & Gutiérrez, S. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.02.001 · Cited by 108
Chen, J.-C., Huang, K., & Lin, W. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.016 · Cited by 104
Sacher, J., Weigl, L. G., Werner, M., Szegedi, C., & HOHENEGGER, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086462 · Cited by 133
“By blocking this rate-limiting step in the mevalonate pathway, endogenous de novo synthesis of cholesterol is prevented and low-density-lipoprotein cholesterol uptake into cells is promoted (Goldstein and Brown, 1990).”
BackgroundZhong, W.-B., Wang, C.-Y., Chang, T.-C., & Lee, W.-S. (2003) · Endocrinology · doi:10.1210/en.2003-0098 · Cited by 104
“Abbreviations: AMC, 7-Amino-4-methylcoumarin; ATC, anaplastic thyroid cancer; CHX, cycloheximide; DTT, dithiothreitol; FOH, farnesol; FPP, farnesyl pyrophosphate; FTase, farnesyl transferase; GGOH, geranylgeraniol; GGPP, geranylgeranyl pyrophosphate; GGTase, geranylgeranyl transferase; HMG-CoA, 3-OH-3-methyl-glutaryl…”
BackgroundInfluentialKeidar, S., Attias, J., Heinrich, R., Coleman, R., & Aviram, M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00145-8 · Cited by 107
“The biochemical site for Ang II action along the cholesterol biosynthesis pathway is probably the HMG CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis [4].”
BackgroundInfluentialMcGee, T. P., Cheng, H. H., Kumagai, H., Omura, S., & Simoni, R. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25630 · Cited by 103
Effects of lovastatin on breast cancer cells: a proteo-metabonomic study
Klawitter, J., Shokati, T., Moll, V., Christians, U., & Klawitter, J. (2010) · Breast Cancer Research · doi:10.1186/bcr2485 · Cited by 103
“The end products include: sterols, involved in membrane integrity and steroid production; ubiquinone (coenzyme Q), involved in electron transport and cell respiration; farnesyl and geranylgeranyl isoprenoids, involved in covalent binding of proteins to membranes; dolichol, which is required for glycoprotein synthesis;…”
BackgroundRegulation of Squalene Synthase, a Key Enzyme of Sterol Biosynthesis, in Tobacco
Devarenne, T. P., Ghosh, A., & Chappell, J. (2002) · PLANT PHYSIOLOGY · doi:10.1104/pp.001438 · Cited by 102
“Sterols are synthesized via the isoprenoid biosynthetic pathway with SS catalyzing the first enzymatic step committing carbon away from the central isoprenoid pathway toward sterol biosynthesis (Goldstein and Brown, 1990).”
BackgroundLiu, L., & Yeh, Y. (2002) · Journal of Nutrition · doi:10.1093/jn/132.6.1129 · Cited by 102
Houten, S. M., van Woerden, C. S., Wijburg, F. A., Wanders, R. J. A., & Waterham, H. R. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200933 · Cited by 102
Lovastatin Induces Apoptosis in Malignant Mesothelioma Cells
Rubins, J. B., Greatens, T. M., Kratzke, R. A., Tan, A., Polunovsky, V. A., & Bitterman, P. B. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709020 · Cited by 102
Dunzendorfer, S., Heininger-Rothbucher, D., Schratzberger, P., Reinisch, N., Kähler, C. M., & Wiedermann, C. J. (1997) · Circulation Research · doi:10.1161/01.res.81.6.963 · Cited by 108
Touraine, R. L., Vahanian, N. N., Ramsey, W. J., & Blaese, R. M. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.16-2385 · Cited by 102
Raiteri, M., Arnaboldi, L., Mcgeady, P., Gelb, M. H., Verri, D., Tagliabue, C., Quarato, P., Ferraboschi, P., Santaniello, E., Paoletti, R., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36722-9 · Cited by 101
Isoprenoids, small GTPases and Alzheimer's disease
Hooff, G. P., Wood, W. G., Müller, W. E., & Eckert, G. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.014 · Cited by 102
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.